Related Experiment Video
Updated: Jun 3, 2025
10:46
Mechanical Stimulation-induced Calcium Wave Propagation in Cell Monolayers: The Example of Bovine Corneal Endothelial Cells
Published on: July 16, 2013
16.2K
Clodronate: The Influence on ATP Purinergic Signaling
Sergio Rosini1, Stefano Rosini2, Gianantonio Saviola3
1Biomaterial Research Center, Livorno, Italy.
Current Rheumatology Reviews
|January 8, 2025
Summary
Clodronate inhibits vesicular nucleotide transporter (VNUT)-mediated release of extracellular adenosine triphosphate (ATP). This mechanism offers therapeutic potential for inflammatory conditions and pain by modulating ATP signaling.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Adenosine triphosphate (ATP) is crucial intracellularly for energy but acts as an extracellular signaling molecule activating purinergic receptors (P2YRs, P2XRs).
- Extracellular ATP signaling influences inflammation, pain, and various physiological processes, making it a key research area.
- Clodronate, a bisphosphonate, uniquely metabolizes into an ATP analog causing mitochondrial dysfunction and osteoclast apoptosis, distinct from N-BPs acting on the mevalonate pathway.
Purpose of the Study:
- To review the therapeutic potential of modulating cellular ATP release.
- To highlight Clodronate's inhibitory effects on the vesicular nucleotide transporter (VNUT) and its impact on extracellular ATP release.
Main Methods:
- Review of existing literature on ATP signaling, purinergic receptors, and Clodronate's mechanism of action.
- Analysis of Clodronate's interaction with VNUT-mediated ATP release.
- Exploration of Clodronate's anti-inflammatory and analgesic effects in various disease models.
Main Results:
- Extracellular ATP, released via VNUT, plays a significant role in inflammation, pain neurotransmission, and liver disease.
- Clodronate demonstrates potent inhibition of VNUT-mediated ATP release.
- Clodronate exhibits anti-inflammatory and analgesic properties through mechanisms involving immune cells and the nervous system.
Conclusions:
- Modulating cellular ATP release presents significant therapeutic opportunities.
- Clodronate's inhibition of VNUT-mediated ATP release offers a promising therapeutic strategy for inflammatory and pain-related conditions.
- Further research into Clodronate's effects on VNUT is warranted to fully explore its therapeutic potential.
More Related Videos
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
11.6K
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
9.2K
Related Concept Videos
01:08Hydrolysis of ATP
74.9K
The bonds of adenosine triphosphate (ATP) can be broken through the addition of water, releasing one or two phosphate groups in an exergonic process called hydrolysis. This reaction liberates the energy in the bonds for use in the cell—for instance, to synthesize proteins from amino acids.
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
If one phosphate group is removed, a molecule of ADP—adenosine diphosphate—remains, along with inorganic phosphate. ADP can be further hydrolyzed to AMP—adenosine...
74.9K
01:48ATP Synthase: Mechanism
13.9K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
13.9K
01:16Calmodulin-dependent Signaling
5.1K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.1K
01:18ATP Synthase: Structure
11.9K
ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...
11.9K
01:27ATP Driven Pumps I: An Overview
7.9K
ATP-driven pumps, also known as transport ATPases, are integral membrane proteins. They have binding sites for ATP located on the membrane's cytosolic side and the ion-conducting domain in the transmembrane region. These pumps use the free energy released from ATP hydrolysis to move the solutes across cell membranes against an electrochemical gradient.
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
There are four main types of ATP-driven pumps - P-type, V-type, F-type, and ABC transporter. All these pumps are of varying complexities and...
7.9K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K